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Abstract
Carbon metabolism and virulence determinant pro-
duction are often linked in pathogenic bacteria, and 
several regulatory elements have been reported to me-
diate this linkage in Staphylococcus aureus. Previously, 
we described a novel protein, catabolite control pro-
tein E (CcpE) that functions as a regulator of the tri-
carboxylic acid cycle. Here we demonstrate that CcpE 
also regulates virulence determinant biosynthesis and 
pathogenesis. Specifically, deletion of ccpE in S. au-
reus strain Newman revealed that CcpE affects tran-
scription of virulence factors such as capA, the first 
gene in the capsule biosynthetic operon; hla, encoding 
α-toxin; and psmα, encoding the phenol-soluble mod-
ulin cluster α. Electrophoretic mobility shift assays 
demonstrated that CcpE binds to the hla promoter. 
Mice challenged with S. aureus strain Newman or its 
isogenic ΔccpE derivative revealed increased disease 
severity in the ΔccpE mutant using two animal mod-
els; an acute lung infection model and a skin infection 
model. Complementation of the mutant with the ccpE 
wild-type allele restored all phenotypes, demonstrat-
ing that CcpE is negative regulator of virulence in S. 
aureus. 
Keywords:  Bacterial Pathogenesis, Staphylococcus au-
reus (S. aureus), Transcription Regulation, Tricarbox-
ylic Acid Cycle (TCA Cycle) (Krebs Cycle), Virulence 
Factor
Introduction
Carbon catabolite repression is a common mechanism uti-
lized by bacteria to optimize their transcriptomes in re-
sponse to the availability of carbon sources (reviewed in 
Ref. 1). Similarly, many pathogenic bacteria use this same 
mechanism to link the nutritional status with the transcrip-
tion of virulence factors (reviewed in Ref. 2). In Staphylo-
coccus aureus, carbon catabolite repression is mediated by 
several regulators such as the catabolite control protein A 
(CcpA),5 a glucose-responsive member of the LacI/GalR 
family of transcriptional regulators (3), CodY, a pleiotropic 
repressor that responds to GTP and branched-chain amino 
acids (4), and RpiRc, a putative ribose-responsive regulator 
that belongs to the RpiR family of transcriptional regulators 
(5). Recently, we identified CcpE as another potential carbon 
catabolite responsive element of S. aureus that controls tran-
scription of tricaboxylic acid (TCA) cycle genes (6). In addi-
tion to regulating metabolism, CcpA, CodY, and RpiRc also 
regulate virulence factor expression (3–5). 
CcpA regulates the expression of exotoxins, such as 
α-toxin (encoded by hla) and toxic shock syndrome toxin-1 
(encoded by tst), and capsule formation in a glucose-respon-
sive manner (3, 7, 8). In addition, CcpA promotes biofilm 
formation under in vitro conditions (9) and alters antibiotic 
susceptibility in methicillin-resistant S. aureus (MRSA) and 
glycopeptide intermediary resistant S. aureus (3). More re-
cently, CcpA was reported to mediate proline and arginine 
auxotrophies during in vitro growth (10, 11), and to contrib-
ute to infectivity of S. aureus in a murine model of staphylo-
coccal abscess formation (10). 
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CodY in S. aureus regulates the expression of virulence fac-
tors such as the cap operon (encoding proteins required for 
capsule biosynthesis), coa (encoding coagulase), fnbA (encod-
ing fibronectin-binding protein A), hla, icaADBC (encoding 
factors required for synthesis of polysaccharide intercellular 
adhesin), and spa (encoding protein A) (4, 12, 13). Although 
inactivation of codY did not markedly affect infectivity of S. 
aureus strain Newman in a murine abscess model, it restored 
the virulence of a mutant lacking the major (p)ppGpp syn-
thase/hydrolase enzyme RSH to wild-type levels, suggesting 
that RSH-dependent derepression of CodY-regulated genes 
is important for virulence of S. aureus (14). More recently, it 
was found that inactivation of codY decreased the infectivity 
of the community-associated MRSA (CA-MRSA) USA300 iso-
late 923 in two murine infection models (15). 
The pentose phosphate pathway regulator RpiRc alters 
the synthesis of several virulence factors such as protein A, 
capsular polysaccharide, and hemolysins, to decrease the 
transcription of RNAIII, the regulatory RNA of the agr lo-
cus, and a major regulator of virulence factor production 
in S. aureus, and to promote biofilm formation under in vi-
tro conditions (5). These observations on RpiRc suggest that 
this regulator might also affect virulence in vivo; however, 
this has not been tested. 
CcpE directly affects transcription of the aconitase-en-
coding gene citB, increases TCA cycle activity during in vitro 
growth (6), and decreases pigment production in S. aureus 
(16). Because both TCA cycle activity (17–22) and pigment 
production (16, 23, 24) affect virulence determinant synthe-
sis and/or infectivity of S. aureus, it is likely that CcpE mod-
ulates the expression of virulence factors and pathogenicity 
in this medically important pathogen. To test this hypothe-
sis, we assessed the effect of ccpE deletion in S. aureus strain 
Newman (25) on the transcription of select virulence factors 
and on its role in infectivity using two unrelated murine in-
fection models. Our data demonstrate that CcpE affects the 
transcription of virulence determinants, and infectivity of S. 
aureus in both in vivo infection models. 
Experimental Procedures
Bacterial Strains and Culture Conditions — The bacterial 
strains and plasmids used in this study are listed in Table 
1. Strains were grown in Luria-Bertani Lennox (LB-L) me-



























a flask-to-medium volume ratio of 10:1. The ΔccpE mutants 
HOM 354 and HOM 355 were obtained by phage transduc-
ing the lox66-aphAIII-lox71–tagged ccpE deletion of THa (6) 
into strains 923 (26) and SA564 (27), respectively. 
Transcriptional Analyses — For Northern blot experiments, 
overnight cultures of S. aureus were diluted to an A600 of 0.05 
into fresh pre-warmed LB-L and grown at 37 °C with 230 
rpm of aeration. Samples were removed from the cultures 
at the indicated times and centrifuged at 9,000 × g and 4 °C 
for 2 min, the culture supernatants were discarded, and the 
cell pellets were snap frozen in liquid nitrogen. Total RNAs 
were isolated according to Ref. 28, and blotting, hybridiza-
tion, and labeling were performed as described (29). Primer 
pairs hla-F/hla-R and RNAIII-F/RNAIII-R (Table 2) were 
used to generate digoxigenin-labeled hla- and RNAIII-spe-
cific probes by PCR labeling, respectively. 
For the quantification of transcripts by real-time reverse 
transcription PCR (qRT-PCR), RNA isolations and qRT-PCRs 
were carried out essentially as described (30). The cDNA (20 
Table 1. Strains and plasmids used in this study
Strain or plasmid      Relevant genotype or characteristic(s)a                                   Ref. or source
S. aureus
 923 CA-MRSA, clinical isolate of pulsotype USA300, Oxar 26
  HOM 354  923 ΔccpE::lox66-aphAIII-lox71, Oxar, Kanr This study
  HOM 355  SA564 ΔccpE::lox66-aphAIII-lox71, Kanr 
 Newman Laboratory strain (ATCC 25904); CP-5 producer 25
 SA564 Low passage human isolate 27
  THa  RN4220 ΔccpE::lox66-aphAIII-lox71, Kanr 6
  TH01  Newman ΔccpE::lox72 6
 TH01c TH01 harboring plasmid pTH2c cis-integrated at the NWMN_0640 locus, leading to a  
      duplication of the NWMN_0640 gene, ccpE+, Tcr 6
Plasmids
 pSB2035 Escherichia coli-S. aureus shuttle plasmid, harboring the cat gene conferring chloramphenicol  
     resistance, and a gfp-lux dual reporter system under the control of the agr P3 promoter; Cmr 32
a. The following abbreviations were used: CA-MRSA, community associated MRSA; Cmr, chloramphenicol resistant;  
Kanr, kanamycin resistant; MLST, multi-locus sequence type; Oxar, methicillin/oxacillin resistant; Tcr, tetracycline resistant.
Table 2. Primers used in this study
         Primer                 Sequence (5′–3′)
Northern probe primer  
 hla-F Forward AGAAAATGGCATGCACAAAAA
 hla-R Reverse TGTAGCGAAGTCTGGTGAAAA
 RNAIII-F Forward GTGATGGAAAATAGTTGATGAG
 RNAIII-R Reverse GTGAATTTGTTCACTGTGTCG
Real-time RT PCR primer  
 capA Forward GAAAATACGCAACTTATCAACATCCA
 capA Reverse TTTTTTCCGAATCTTGTTTATGACC
crtM Forward ACGCTTTTGACTTGTTACCAGAAGA
 crtM Reverse AAATTGCCCAAACCGCTTT
 Hla Forward GAACCCGGTATATGGCAATCAA
 Hla Reverse GGAAGTTCTCTGCTGCTTTCATAG
 RNAIII Forward AGGAGTGATTTCAATGGCACAAG
 RNAIII Reverse TGTGTCGATAATCCATTTTACTAAGTCA
 Psma Forward ATCAACAACTCATCACTATGTTAAATCAAC
 Psma Reverse GCCATCGTTTTGTCCTCCTGT
 gyrB Forward GACTGATGCCGATGTGGA
 gyrB Reverse AACGGTGGCTGTGCAATA
EMSA primer  
 agr P2/3 Forward CCATCACATCTCTGTGATCTAG
 agr P2/3 Reverse CTCTCCTCACTGTCATTATACG
 capA p Forward ATCATATGATTATAAGCAATAA
 capA p Reverse GTAATACTTCTTTAATTTTTG
 hla p Forward TAATTAATACCCTTTTTCTCTATTTC
 hla p Reverse GTTACTGAGCTGACTATACGTGTTTTCAT
 psma p Forward CAAATTCATGAGCTTAACCTC
 psma p Reverse GAATTGTTCGATTAAGCTTTTG
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ng/reaction) was used for real-time amplification using the 
primers listed in Table 2. mRNA levels were normalized 
against the mRNA level of gyrB, which is constitutively ex-
pressed under the conditions analyzed (31). The amounts of 
transcripts were expressed as the n-fold difference relative to 
the control gene (2−ΔCT, where ΔCT represents the difference 
in threshold cycle between the target and control genes). 
Electrophoretic Mobility Shift Assays — DNA probes for 
electrophoretic mobility shift assays (EMSAs) were gener-
ated by PCR using S. aureus strain Newman chromosomal 
DNA as a template, and primer pairs (Table 2) that ampli-
fied the DNA regions preceding the capA, hla, hld, purA, 
and psmα ORFs. The 5′-ends of the double-stranded PCR 
products were labeled using [γ-32P]ATP and T4 polynucle-
otide kinase. A typical assay mixture contained (in 20 μl) 
10 mm Tris-HCl, pH 7.5, 50 mm KCl, 1 mm dithiothreitol, 5 
mm MgCl2, 0.1 μg of nonspecific competitor (poly(dI-dC)), 
2.5% (v/v) glycerol, 0.05% (v/v) Igepal, radioactive DNA 
probe (2000 cpm ml−1) and various amounts (0, 15, 65, 130, 
and 200 nm) of purified CcpE. After 20 min of incubation at 
room temperature, 20 μl of this mixture was loaded into a 
native 5% (w/v) polyacrylamide Tris borate-EDTA Ready 
Gel (Bio-Rad) and electrophoresed in 1% Tris borate-EDTA 
(v/v) buffer for 1 h at 100 V cm−1. Radioactive species were 
detected by autoradiography using direct exposure to films. 
Radioactivity labeled promoter probes shifting with CcpE 
were additionally coincubated with increasing amounts of 
a nonspecific promoter probe and cold competitor, respec-
tively, to demonstrate specificity of the shifting reaction. 
Luciferase Assay — For assaying luciferase activities of S. 
aureus cells harboring plasmid pSB20235 (32), bacteria were 
cultivated in LB-L supplemented with 10 μg ml−1 chloram-
phenicol. Luciferase measurements were carried out es-
sentially as described (33). 200-μl samples of the cell sus-
pensions were removed at the time points indicated, and 
transferred to the wells of a 96-well clear-bottomed black 
plate (Greiner). The plate was placed in a Wallac Victor2 
1420 Multilabel Counter (PerkinElmer Life Sciences), and lu-
minescence readings were taken for 5 s at 37 °C. 
Capsular Polysaccharide 5 (CP-5) Production — CP-5 pro-
duction was determined by indirect immunofluorescence 
as described (3), using mouse immunoglobulin M monoclo-
nal antibodies to CP-5 (34). Quantification of CP-5-positive 
cells was done by determining the numbers of 4′,6-diamid-
ino-2-phenylindole (DAPI) and CY-3-positive cells using the 
software program CellC (35) (Institute of Signal Processing, 
Tampere University of Technology, Finland). Immune fluo-
rescence intensities were analyzed using the MetaVueTM Re-
search Imaging System (Molecular Devices). Briefly, from 
each image 80 bacteria detected by DAPI were randomly se-
lected and the regions were transferred to the correspond-
ing CY-3-stained image. Intensities of the single bacteria 
were measured and the distribution of intensities analyzed 
by the software program GraphPad Prism (GraphPad Soft-
ware, Inc.). 
Pigment Measurements — Bacteria were harvested after 24 
h of growth on tryptic soy agar and carotenoids were ex-
tracted as described (36). The optical densities at 465 nm of 
the methanol extracts were measured and normalized in ref-
erence to the values obtained with the wild-type extracts, 
which were set at 100. 
Animal Models — Eight-week-old female C57BL/6N mice 
were purchased from Charles River Laboratories (Sulzfeld, 
Germany) and kept under specific pathogen-free conditions 
according to the regulations of German veterinary law. All 
animal studies were performed with the approval of the lo-
cal State Review Boards. 
The murine lung infection model was done essentially 
as described (37). Eight-week-old C57BL/6N mice were 
slightly anesthetized by intraperitoneal injection of 2.6 mg 
of ketamin hydrochloride (Pfizer, Berlin, Germany) and 0.18 
mg of xylazin hydrochloride (Bayer, Leverkusen, Germany) 
per mouse and infected intranasally with 5 × 107 colony 
forming units (cfu) of S. aureus. Twenty-four hours post-in-
fection, the animals were euthanized, the tracheae were can-
nulated, and a bronchoalveolar lavage was performed (three 
times with 1 ml of phosphate-buffered saline). The bron-
choalveolar lavage fluid (BALF) was centrifuged at 300 × g 
for 10 min at 4 °C to obtain alveolar cells, which were sus-
pended in 1 ml of PBS. Total cell numbers in BALF were de-
termined using a Neubauer hemocytometer. To identify the 
bacterial load of the lungs 24 h post-infection, whole lungs 
were homogenized in 1 ml of PBS, and serial dilutions were 
plated onto sheep blood agar. CFU were counted after incu-
bation overnight at 37 °C. 
The footpad swelling model was carried out as described 
(38). Age-matched mice were inoculated subcutaneously 
with 1 × 107 cfu of S. aureus into the left hind footpad, and 
footpad swelling was measured daily with a micrometric 
caliper in reference to the uninfected footpad. 
Cytok ine  Determinat ions  — Levels  o f  murine 
interleukin-1β (IL-1β), keratinocyte-derived chemokine 
(KC), and granulocyte-colony stimulating factor (G-CSF) in 
cell-free BALFs and lung homogenates were determined by 
commercially available sandwich-type ELISAs, according to 
the manufacturer’s instructions (R&D Systems, Wiesbaden-
Nordenstadt, Germany). 
Statistical Analyses — Statistical significance was assessed 
using the Mann-Whitney U test. p values <0.05 were consid-
ered significant. 
Results
Influence of a ccpE Deletion on RNAIII Transcription — 
Given the importance of the agr locus for virulence determi-
nant production in S. aureus (reviewed in Refs. 39 and 40), 
we tested whether CcpE affects transcription of this regu-
latory system. Northern blot analysis revealed that all three 
strains, Newman, TH01, and TH01c, produced RNAIII tran-
scripts in a growth phase-dependent manner, with a peak 
transcription rate at the transition from the exponential 
growth phase to post-exponential growth phase (i.e. 6 h) 
(Figure 1). However, deletion of ccpE increased the post-ex-
ponential growth phase accumulation of RNAIII transcripts 
in TH01, suggesting that CcpE negatively affects RNAIII 
transcription. To test this suggestion, we transformed an 
RNAIII transcriptional reporter plasmid, pSB2035, (32) into 
strains Newman, TH01, and TH01c. This plasmid harbors 
a gfp-luxABCDE dual reporter system under control of the 
RNAIII transcription-driving agr P3 promoter. Similar to 
the Northern blot data (Figure 1B), luciferase activity as-
says revealed a growth phase-dependent transcription of 
RNAIII (Figure 1C). In addition, we observed that deletion 































































of ccpE increased transcription of RNAIII, confirming that 
the increased amount of RNAIII in the TH01 mutant is due 
to increased RNAIII transcription and not due to decreased 
RNAIII degradation. To test whether CcpE might exert this 
effect via direct binding to the agr P3 promoter, EMSAs were 
performed with purified CcpE and a radioactively labeled 
PCR probe covering the agr P2/3 promoter (Figure 1D). No 
mobility shifts were observed over a range of protein con-
centrations, suggesting that CcpE does not directly interact 
with the agr P3 promoter to modulate RNAIII transcription. 
CcpE Directly Influences hla Transcription — α-Toxin is a 
major virulence factor of S. aureus, and its synthesis is regu-
lated at multiple levels, including transcriptional and post-
transcriptional mechanisms (3, 41–44). Regulation of hla 
transcription is also influenced by the carbon catabolite re-
sponsive elements CcpA and CodY (3, 4, 15, 45); hence, we 
hypothesized that hla transcription might be regulated by 
CcpE as well. Support for this hypothesis can be seen in 
the Northern blot analysis of hla transcription (Figure 2A), 
where hla mRNA levels are much greater in the ΔccpE mu-
tant strain TH01 in all growth phases relative to the wild-
type and cis-complemented derivative strain TH01c. To 
quantify the effect of ccpE deletion on hla transcription, we 
performed qRT-PCRs on strains Newman, TH01, and TH01c 
throughout a complete growth cycle (Figure 2B). Consistent 
with our Northern blot data, we observed a growth phase-
dependent transcription of hla, with a peak in the post-ex-
ponential growth phase (9 h). Deletion of ccpE resulted in a 
massive up-regulation (30 to 60-fold) of hla transcription in 
strain TH01. Complementation of TH01 with a ccpE wild-
type allele restored hla mRNA levels to those seen in the 
wild-type strain. To exclude that this effect of CcpE was spe-
cific for S. aureus strain Newman, we deleted ccpE in two 
genetically unrelated S. aureus strains, CA-MRSA USA300 
isolate 923 (26) and the low passage human isolate SA564 
(27), and assessed hla transcription of these strain pairs (Fig-
ure 2C). Deletion of ccpE again strongly increased the tran-
scription of hla in both strains, suggesting that the repres-
sive effect of CcpE on hla transcription is independent of the 
genetic background. To assess whether CcpE directly regu-
lates transcription of hla, we performed EMSAs with the hla 
promoter as probe (Figure 2D). A clear and dose-dependent 
shift of CcpE with the radioactively labeled hla promoter 
probe was observed, which was not affected by the addition 
of a nonspecific promoter probe (data not shown) but was 
invertable by adding excessive amounts of cold competitor, 
suggesting that CcpE directly controls transcription of hla. 
CcpE Promotes Capsule Formation — Capsular polysaccha-
ride is another important virulence factor of S. aureus, whose 
synthesis is intimately linked to the nutritional status of the 
bacterium (3, 5, 12). Our results (Figure 3) demonstrate that 
in addition to CcpA, CodY, and RpiRc, CcpE also modu-
lates transcription of the cap operon and the elaboration of a 
capsule. As expected, when S. aureus was cultivated in LB-
L, the first gene of the cap operon (capA) was predominantly 
transcribed during the later stages of growth (Figure 3A). 
Deletion of ccpE in TH01 strongly decreased accumulation 
of capA mRNA throughout the growth cycle. cis-Comple-
mentation of TH01 with the wild-type ccpE allele restored 
capA mRNA levels to those found in the isogenic wild-type 
strain Newman. Consistent with the transcriptional data, 
a reduced number of capsular polysaccharide poitive cells
Figure 1. Effect of the ccpE deletion on RNAIII transcription in S. 
aureus Newman. A, growth characteristics of S. aureus strains New-
man (black symbols), TH01 (white symbols), and TH01c (gray sym-
bols) cultured in LB-L at 37 °C and 230 rpm. Time points of sampling 
for downstream applications (reporter assays, qRT-PCRs) are indicated 
by arrows. B, Northern blot of RNAIII transcription in strains Newman, 
TH01 (ΔccpE), and the complemented TH01c during growth in LB-L. 
Approximate transcript sizes are indicated on the left. Ethidium bro-
mide-stained 16 S rRNA are presented to indicate equivalent RNA load-
ing. C, agr P3 promoter-driven luciferase activities of plasmid pSB2035 
harboring derivatives of strains Newman (black bars), TH01 (white 
bars), and TH01c (gray bars) during growth in LB-L. Luciferase activi-
ties were determined at the time points indicated. Data shown are the 
mean ± S.D. of six independent experiments. Mann-Whitney U test; *, 
p < 0.05; **, p < 0.01. D, binding activity of CcpE to the agr P2/3 pro-
moter region. The PCR-amplified DNA fragments were radioactively la-
beled and incubated with the amount of purified CcpE indicated. The re-
sults are representative of at least two independent experiments. RLU, 
relative light units.
t H e  c a t a b o l i t e  c o n t r o l  p r o t e i n  e  a f f e c t s  v i r u l e n c e  a n d  p a t H o g e n e s i s  o f  s.  a u r e u s   29705
was observed with the ΔccpE mutant (Figure 3B). Although 
about 69 ± 6% of the Newman cells and 75 ± 8% of the TH01c 
cells incubated with the CP-5 antibodies produced clear fluo-
rescence signals after 24 h of growth in LB-L, in the TH01 cell 
pool only 35 ± 7% of the cells emitted detectable amounts of 
fluorescence. Similarly, a ~10-fold decrease in the mean fluo-
rescence intensity per cell was observed with the ΔccpE mu-
tant (Figure 3B) when compared with cells of the wild-type 
and complemented derivative TH01c. To determine whether 
the CcpE-dependent regulation of capA was due to an inter-
action with the capA promoter, EMSAs were performed with 
CcpE and a radioactively labeled probe of the capA promoter. 
In contrast to the hla promoter, CcpE did not shift the capA 
promoter probe at any of the CcpE concentrations tested (Fig-
ure 3C), indicating that CcpE indirectly influences cap operon 
transcription and capsule formation. 
CcpE Alters Transcription of the Phenol-soluble Modulin α 
(psmα) Cluster — Phenol-soluble modulins are a small group 
of cytolytic and immunomodulating peptides that are im-
portant virulence determinants of S. aureus, especially in 
CA-MRSA USA300 isolates (reviewed in Ref. 46). The S. au-
reus Newman genome harbors two psm operons, psmα and 
psmβ, which are transcriptionally affected by regulators 
such as SarA and AgrA (40, 47). To determine whether CcpE 
Figure 2. Effect of the ccpE deletion on hla transcription in S. au-
reus. A, Northern blot of hla transcription in strains Newman, TH01 
(ΔccpE), and the complemented TH01c during growth in LB-L. Approxi-
mate transcript sizes are indicated on the left. Ethidium bromide-stained 
16 S rRNA are presented to indicate equivalent RNA loading. B, quan-
titative transcript analysis of hla by qRT-PCR of strains Newman (black 
bars), TH01 (white bars), and TH01c (gray bars) during growth in LB-
L. C, quantitative transcript analysis of hla by qRT-PCR of strains 923, 
HOM 354 (923 ΔccpE), SA564, and HOM 355 (SA564 ΔccpE) after 9 
h of growth in LB-L. mRNA levels are expressed relative to gyrase B 
(in numbers of copies per copy of gyrB). The data presented in B and 
C are the mean ± S.D. of three independent experiments each deter-
mined in duplicate. Mann-Whitney U test: *, p < 0.05; **, p < 0.01. D, 
binding activity of CcpE to the hla promoter of strain Newman. The 
PCR-amplified DNA fragments (100 ng/lane) were radioactively labeled 
and incubated with the amount of purified CcpE in the absence and 
presence of cold competitor as indicated. The results are representa-
tive of at least two independent experiments. 
Figure 3. Effect of the ccpE deletion on capsule formation in S. au-
reus Newman. A, quantitative transcript analysis of capA by qRT-PCR 
of strains Newman (black bars), TH01 (ΔccpE, white bars), and TH01c 
(complemented derivative, gray bars) during growth in LB-L. mRNA lev-
els are expressed relative to gyrase B (in numbers of copies per copy 
of gyrB). The data presented are the mean ± S.D. of three indepen-
dent experiments each determined in duplicate. Mann-Whitney U test: 
*, p < 0.05; **, p < 0.01. B, CP-5 expression of strains Newman, TH01, 
and TH01c during growth in LB-L. Bacteria were grown to an A600 of 
0.5, stained with DAPI, marked with CP-5-specific monoclonal antibod-
ies, and stained with Cy-3-conjugated anti-mouse antibodies (CY-3). 
Numbers in parentheses indicate the mean fluorescence intensities ± 
S.D. per cell (n = 80). C, binding activity of CcpE to the cap promoter. 
The PCR-amplified DNA fragments were radioactively labeled and incu-
bated with the amount of purified CcpE indicated. The results in B and 
C are representative of at least two independent experiments. 
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influences psm transcription, we assessed psmα and psmβ 
transcription using qRT-PCR. Deletion of ccpE had a neg-
ligible effect on psmβ transcription (data not shown); how-
ever, we observed a significant reduction of psmα transcripts 
in strain TH01 compared with the wild-type strain (Figure 
4A). Complementation of TH01 with a ccpE wild-type al-
lele restored psmα mRNA levels to that seen in the wild-
type strain. EMSAs performed using CcpE and the psmα 
promoter as a probe failed to shift the radiolabeled probe 
with any of the protein concentrations tested (Figure 4B), 
suggesting an indirect effect of CcpE on psmα transcription. 
CcpE Decreases Pigment Production — Most S. aureus strains 
produce the carotenoid pigment staphyloxanthin, which is re-
sponsible for the yellowish-orange appearance of this bacte-
rium (48). In line with a previous publication (16), we noticed 
an increase in pigment production after 24 h of growth on 
tryptic soy agar, and this phenotype was reverted by intro-
ducing a functional ccpE into this mutant (Figure 5). The syn-
thesis of staphyloxanthin is encoded within the crtOPQMN 
operon (48); hence, to determine whether CcpE affects tran-
scription of crtOPQMN, we assessed crtM mRNA levels in 
strains Newman, TH01, and TH01c using qRT-PCR. Con-
trary to the findings reported by Lan and colleagues (16), our 
results suggest that transcription of crtOPQMN appears to 
be independent of CcpE (Figure 5C). Similarly, inactivation 
of ccpE in strains 923 and SA564 significantly increased the 
pigment contents of mutant cells compared with wild-type, 
without affecting crtM transcription, suggesting that this phe-
nomenon is not strain-dependent (Figure 5). 
CcpE Attenuates Virulence in Two Murine Infection Models 
— Deletion of ccpE in S. aureus strain Newman augmented 
transcription of the global virulence regulator RNAIII (Fig-
ure 1) and increased α-toxin (hla) mRNA (Figure 2). Given 
the effect of CcpE on virulence factor transcription in vi-
tro, we hypothesized that CcpE might alter infectivity of S. 
aureus in vivo. To address this hypothesis, we assessed the 
ability of Newman, TH01, and TH01c strains to cause dis-
ease in two different murine infection models. In a murine 
pneumonia model, C57BL/6N mice were infected intrana-
sally with strains Newman, TH01, or TH01c, and the bac-
terial load in the lungs and the total amount of eukaryotic 
cells in BALFs at 24 h post-infection were determined (Fig-



























in the lungs of mice relative to the wild-type and comple-
mented strains (Figure 6A). Similarly, we observed a signif-
icant increase in total cells in BALFs of the TH01 challenged 
mice (Figure 6B), indicating a more severe infection. This 
increase in total cell numbers correlated with an increased 
number of neutrophils in BALFs of TH01 challenged mice 
(Figure 6C), and this also correlated with increased concen-
trations of the neutrophil mobilization stimulating factor G-
CSF (49) (Figure 6D). Complementation of the ΔccpE mutant 
restored all virulence traits back to wild-type levels, con-
firming that all observed alterations were caused by CcpE. 
To exclude that this CcpE effect is specific for strain New-
man, we additionally infected mice intranasally with strain 
SA564 and its ΔccpE derivative HOM 355, respectively. In 
line with our observations made with the strain triplet New-
man/TH01/TH01c, we observed significantly increased cfu 
numbers in the lung tissues of mice that have been infected 
Figure 4. Effect of the ccpE deletion on psmα transcription in S. 
aureus Newman. A, quantitative transcript analysis of psmα by qRT-
PCR of strains Newman (black bars), TH01 (white bars), and TH01c 
(gray bars) during growth in LB-L. mRNA levels are expressed rela-
tive to gyrase B (in numbers of copies per copy of gyrB). The data pre-
sented are mean ± S.D. of three independent experiments each deter-
mined in duplicate. Mann-Whitney U test: *, p < 0.05; **, p < 0.01. B, 
binding activity of CcpE to the psmα promoter. The PCR-amplified DNA 
fragments were radioactively labeled and incubated with the amount of 
purified CcpE indicated. The results are representative of at least two 
independent experiments. 
Figure 5. Effect of the ccpE deletion on pigment production in S. 
aureus. A, pigmentation displays of S. aureus strains grown for 24 h at 
37 °C on tryptic soy agar plates. B, measurement of carotenoid pigment 
contents in S. aureus cells grown for 24 h at 37 °C on tryptic soy agar. 
The relative optical density units at 465 nm were normalized to those of 
wild-type, which were set at 100. The data presented are mean ± S.D. 
of five independent experiments. Mann-Whitney U test: *, p < 0.05; **, p 
< 0.01. C, quantitative transcript analysis of crtM by qRT-PCR of S. au-
reus cells grown for 24 h at 37 °C on tryptic soy agar. mRNA levels are 
expressed relative to gyrase B (in numbers of copies per copy of gyrB). 
The data presented are mean ± S.D. of three independent experiments 
each determined in duplicate. 
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with the SA564 ccpE mutant (Figure 7), demonstrating that 
this virulence diminishing effect of CcpE is not specific for 
strain Newman. 
To substantiate these findings in another in vivo model, 
we utilized a murine footpad infection model (38). In this 
model, bacteria are inoculated into the left hind footpad of 
mice and footpad swelling ratios are determined on a daily 
basis for up to 12 days (Figure 8). Consistent with our ob-
servations using a lung infection model, we observed en-
hanced footpad swelling in mice challenged with the New-
man ΔccpE mutant relative to the isogenic wild-type and 
complemented strains (Figure 8). Swelling was most signif-
icantly increased early in the infection process (days 1 to 4) 
and in the later stages of the infection (days 8 to 12) when 
compared with the values obtained with the wild-type and 
TH01c challenged mice groups. 
Discussion
The nosocomial pathogen S. aureus is known to link its 
virulence factor production with central metabolic path-
ways (3–5, 8, 9, 13, 22). This linkage is mediated via at least 
three metabolite responsive regulators; namely, CcpA, (3, 
8), CodY (13), and RpiRc (5). Data presented here demon-
strate that CcpE represents a fourth regulatory protein that 
connects virulence factor synthesis with the central metabo-
lism, specifically the TCA cycle (Figure 9) (6). 
Although most effects of CcpE on virulence factor syn-
thesis were indirect, possibly via regulation of TCA cycle 
activity (22, 27, 50), a direct link between CcpE and hla tran-
scription was established. In a murine pneumonia model, 























pathogenesis of S. aureus (51, 52); specifically, the level of 
α-toxin correlated with disease severity in this animal model 
(53). Mechanistically, α-toxin increases cytokine synthesis, 
enhances neutrophil recruitment, and stimulates the NLRP3 
(NOD-like receptor family, pyrin domain containing 3) in-
flammasome in lungs, leading to massive inflammatory re-
sponse and tissue destruction (54, 55). Consistent with these 
observations, deletion of ccpE increased hla transcription 
(Figure 2) and increased the bacterial loads and neutrophil 
Figure 6. Effect of the ccpE 
deletion on infectivity of 
S. aureus Newman in an 
acute murine lung infection 
model. C57BL/6N mice were 
infected intranasally with 5 × 
107 cells of S. aureus strain 
Newman (black symbols), 
TH01 (ΔccpE, white symbols), 
and TH01c (complemented 
mutant, gray symbols), 
respectively (n = 8–10 per 
group). Mice were euthanized 
24 h post-infection, BALFs 
were collected, and lungs 
were homogenized in PBS to 
determine the bacterial loads 
and cytokine concentrations 
in this tissue. A, bacterial 
loads in the lungs of infected 
mice. B, total eukaryotic 
cell contents in BALFs. 
Each symbol represents an 
individual mouse. Horizontal 
bars indicate the median of 
all observations. C, ratios of 
monocytes and neutrophils 
in BALFs of infected mice. D, 
G-CSF concentrations in lungs 
and cell-free BALFs of infected 
mice. Data are presented 
as mean ± S.E. (n = 8–10). 
Mann-Whitney U test: *, p < 
0.05; **, p < 0.01. 
Figure 7. Effect of the ccpE deletion on infectivity of S. aureus 
SA564 in an acute murine lung infection model. C57BL/6N mice 
were infected intranasally with 5 × 107 cells of S. aureus strain SA564 
(black symbols) and HOM 355 (ΔccpE, white symbols), respectively (n 
= 7–8 per group). Mice were euthanized 24 h post-infection, and lungs 
were homogenized in PBS to determine the bacterial loads in this tis-
sue. Each symbol represents an individual mouse. Horizontal bars indi-
cate the median of all observations. Mann-Whitney U test: *, p < 0.05. 
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contents in the lungs of mice (Figs. 6 and 7), suggesting that 
CcpE might influence the virulence of S. aureus during lung 
infections via transcriptional regulation of hla. 
In addition to directly interacting with hla, ccpE deletion 
increased RNAIII levels, which likely contributed to the al-
tered pathogenesis of the ΔccpE mutant in both animal mod-
els. RNAIII is the RNA regulator of the agr locus encoded 
quorum sensing system (reviewed in Refs. 39 and 40) and it 
codes for a small lytic peptide called δ-toxin, which is a che-
moattractant for neutrophils (50). RNAIII is predominantly 
transcribed when a threshold level of bacteria is achieved 
(56, 57). In its regulatory function, RNAIII promotes the ex-
pression of many exoproteins including α-toxin, either di-
rectly or via control of a repressor protein known as Rot 
(43, 58). Mutations in agr have been shown to attenuate vir-
ulence in several animal models (59–63) including murine 
models of pneumonia (52, 64) and skin infections (65–67). 
When the peptide δ-toxin is translated from RNAIII, it is 
produced in two forms; one without an N-terminal formyl 
group on the methionine, and one containing a formylated 
methionine (50). Formylated δ-toxin is a potent neutrophil 
chemoattractant, suggesting that increased neutrophils in 
the lungs on TH01-infected mice may be due to an increase 
in δ-toxin synthesis. 
Alterations in the synthesis of virulence factors and 
RNAIII will likely alter the immune response to the in-
fection. The BALF cytokine profiles of mice infected with 
strains Newman, TH01, and TH01c were similar with 
Figure 8. Effect of the ccpE deletion on infectivity of S. aureus 
Newman in a systemic murine footpad infection model. 1 × 107 
cells of S. aureus strain Newman (black symbols) and its derivatives 
TH01 (ΔccpE, white symbols), and TH01c (complemented mutant, gray 
symbols) were injected subcutaneously into the footpads of C57BL/6N 
mice, and swelling of the footpads were measured in reference to the 
uninfected footpads at the time points indicated. Data shown represent 
the mean ± S.D. of 8 mice per group. Mann-Whitney U test: *, p < 0.05. 
Figure 9. Proposed regulatory role of CcpE on virulence factor production and pathogenicity of S. aureus. Under glucose-rich conditions, 
TCA cycle activity is repressed in S. aureus via CcpA. When glucose concentrations become growth limiting, the transcription of TCA cycle genes 
is de-repressed in a CcpE-dependent manner, which directly promotes TCA cycle activity via direct transcriptional control of the aconitase encod-
ing gene citB. An active TCA cycle augments capsule formation via an increased transcription of the cap operon. Additionally, it decreases pigment 




green diagonal arrows and negative effects by red diagonal arrows. Direct regulation of CcpE is displayed by black connecting lines, and indirect 
regulation by gray lines. Arrows indicate a stimulatory effect, and perpendicular lines a repressive effect. 
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respect to keratinocyte-derived chemokine and IL-1β, how-
ever, G-CSF was higher in BALFs and lung homogenates 
from TH01 challenged mice relative to mice infected with 
the wild-type strain. G-CSF was originally characterized in 
hematopoietic cells to stimulate the proliferation and dif-
ferentiation of neutrophil granulocyte precursors. In addi-
tion, G-CSF functions to recruit polymorphonuclear leuko-
cytes to the lung (68), and its expression in lung tissue is 
stimulated by microbial infections (69–72). Recently, Hua et 
al. (73) observed in a mouse pneumonia model that preim-
munization with an anti-α-toxin antibody significantly de-
creased the G-CSF contents in BALFs of mice infected with 
S. aureus. Based on this observation, it is reasonable to spec-
ulate that an increase in α-toxin synthesis (Figure 2) would 
increase G-CSF production (Figure 6D), resulting in an in-
crease in neutrophil recruitment (Figure 6C). 
Transcription of RNAIII is primarily promoted by AgrA, 
the response regulator of the two-component system en-
coded by the agr locus (74). In addition, AgrA also promotes 
transcription of the psm operons (40). Because we observed 
divergent effects of CcpE on RNAIII and psmα transcription 
(Figs. 1 and 4), we can largely exclude that CcpE modulates 
RNAIII production via activation of AgrA. Similarly, the agr 
system promotes capsule synthesis (75–77); however, capA 
mRNA levels were decreased in the ΔccpE mutant despite 
an increase in RNAIII transcript levels (Figs. 1 and 3). In-
terestingly, Somerville and colleagues (20, 27) observed in-
creased RNAIII levels and an impaired capsule biosynthe-
sis in TCA cycle mutants in which the aconitase-encoding 
gene citB (syn. acnA) was inactivated, demonstrating a link 
between TCA cycle activity, capsule formation, and RNAIII 
production. It is possible that CcpE modulates RNAIII tran-
scription and capsule biosynthesis via regulation of TCA cy-
cle activity. However, the effect of TCA cycle inactivation on 
capsule synthesis is tied to a lack of oxaloacetate for gluco-
neogenesis (20), and it is still unclear how TCA cycle activ-
ity affects transcription of RNAIII. A potential factor might 
be aconitase itself. This key enzyme of the TCA cycle is re-
ported in Bacillus subtilis to act as a bifunctional protein that 
possesses enzymatic activity and functions as an RNA-bind-
ing regulatory protein (78–80). Similar to B. subtilis, apo-
aconitase binds to iron-responsive elements in mRNA (G. 
A. Somerville, unpublished data.), raising the possibility of 
a direct interaction between aconitase and the highly struc-
tured RNAIII. Additionally, CcpE might affect RNAIII syn-
thesis and capsule formation via pH alterations. We have 
recently shown that in vitro cultivation of the ccpE deletion 
mutant in LB-L led to a significantly reduced alkalinization 
of the culture medium during later stages of growth (6–12 
h) compared with the wild-type culture (6). Alkaline growth 
conditions were previously reported to repress RNAIII pro-
duction (81), and to augment capsule formation (82, 83), 
consistent with our findings of increased RNAIII transcrip-
tion and decreased capA transcription in TH01 during the 
later growth stages in LB-L (Figs. 1 and 3). 
In conclusion, CcpE modulates the expression of several 
major virulence factors of S. aureus, which affects its patho-
genesis. Given its mostly repressive effect on virulence de-
terminant production, it can be assumed that CcpE serves 
as an attenuator of virulence in this clinically important 
pathogen. 
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